Latest Articles
Endometrial cancer: Why the patient’s voice needs to be part of the treatment plan - MSN
Endometrial cancer: Why the patient’s voice needs to be part of the treatment plan MSN
Published: May 23, 2026, 11:20 p.m.
Merck Announces Positive Phase 3 Results for Endometrial Cancer Drug - HarianBasis.co
Merck Announces Positive Phase 3 Results for Endometrial Cancer Drug HarianBasis.co
Published: May 23, 2026, 1:10 p.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - MSN
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial MSN
Published: May 23, 2026, 12:41 p.m.
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints - Yahoo Finance
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints Yahoo Finance
Published: May 23, 2026, 12:01 p.m.
Edinburgh patient with cancer 'many haven't heard of' to feature in BBC documentary - MSN
Edinburgh patient with cancer 'many haven't heard of' to feature in BBC documentary MSN
Published: May 23, 2026, 3:48 a.m.
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer - Pharmacy Times
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer Pharmacy Times
Published: May 22, 2026, 4:14 p.m.
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? - Pharmacy Times
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? Pharmacy Times
Published: May 22, 2026, 4:29 a.m.
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 - OncLive
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive
Published: May 22, 2026, 3:43 a.m.
Research Suggests Powerful Cancer Prevention Combo: GLP-1RAs and Progestins for Women at Risk - Medical Dialogues
Research Suggests Powerful Cancer Prevention Combo: GLP-1RAs and Progestins for Women at Risk Medical Dialogues
Published: May 22, 2026, 12:30 a.m.
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com UK
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com UK
Published: May 21, 2026, 8:34 p.m.
Link copied to clipboard!